Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
interferon alpha-2b (Intron-A) (1 trial)
lovastatin (mevacor) (1 trial)
Melanoma (Phase 2)
Trials (1 total)
Trial APIs (2 total)